Updated Oct 16, 2018

Low-cost Salivary Progesterone Testing for Detecting the Risk of Preterm Births in Rural Community Settings of India

The innovation has no owner

CLAIM IT

Snapshot

Focus Areas:

Maternal Newborn and Child Health

Maternal Newborn and Child HealthSEE LESS

Implemented In:

India

IndiaSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

The study is aimed at developing a novel, low-cost test for pre-term birth (PTB). The proposal is intended to test and validate the low-cost salivary progesterone as a point-of-care (POC) test for detecting risk of PTBs in rural community settings of India. Offering non-invasive sampling of biological fluid that is easy to collect, the study allows validation of saliva from a large cohort of pregnant women residing in low-resource community settings. It is planned to obtain single saliva sample from each participant and determine its predictive characteristics against gestation at delivery and other obstetrics and neonatal outcomes.

Milestones

Sep 2016
Date Unknown
New Country
India